Reuters logo
BRIEF-Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent
February 8, 2017 / 10:37 PM / 10 months ago

BRIEF-Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent

Feb 8 (Reuters) - Regeneron Pharmaceuticals Inc :

* Regeneron Pharmaceuticals Inc says appeals court grants stay of permanent injunction for praluent (alirocumab) during appeals process

* Regeneron -Sanofi and Regeneron will continue marketing, selling and manufacturing praluent in U.S. during appeal process

* Regeneron Pharmaceuticals Inc - injunction is not applicable outside U.S. or to clinical trials which are continuing as planned

* Regeneron Pharmaceuticals Inc - anticipated launch of praluent in 15 additional countries in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below